Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2010
03/24/2010CN101676408A 6,11 type human papillomavirus fluorescence quantitative PCR detection method and kit thereof
03/24/2010CN101676407A Primer for enterovirus 71 type nucleic acid detection, probe and kit
03/24/2010CN101676406A Primer for coxsackie virus A16 nucleic acid detection, probe and kit
03/24/2010CN101676405A Mycobacterium tuberculosis fluorescence quantitative PCR detection method and kit thereof
03/24/2010CN101676404A A method and agent for forecasting II type diabetes susceptibility using mitochondrion ND2 gene SNP
03/24/2010CN101676400A Expression of biologically active polypeptides in duckweed
03/24/2010CN101676391A A system capable of stably expressing cell cycle factor FoxM1 and its medical use
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101676388A Avian cell lines for the production of useful substances
03/24/2010CN101676301A Antibody for inhibitting growth of colorectal carcinoma and its use in preparation of medicament and kit
03/24/2010CN101676300A Antibody for inhibitting growth of colorectal carcinoma and its use in preparation of diagnostic agent of adenocarcinoma
03/24/2010CN101675993A melan-a peptide analogue-virus-like-particle conjugates
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/24/2010CN100595283C Method for screening of a lipase having improved enzymatic activity using yeast surface display vector and the lipase
03/24/2010CN100595278C Genic engineering strain of expression recombinant prawn peptide Pen24 and its use
03/24/2010CN100595277C Form board stationary beta hair clip ring analog and use in bacteriophage exhibition
03/24/2010CN100595276C Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
03/24/2010CN100595275C Immortalized preosteoblasts and method for their production
03/24/2010CN100595274C Pre-adipose cell lines
03/24/2010CN100595269C Construction of bacterial strain producing alpha-oxoglutarate recombination and method for producing alpha-oxoglutarate by the same
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100594934C Amended recombinant cells (ARCs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants
03/24/2010CN100594931C The pIFN-gamma gene adjuvant for pig vaccine and its prepn process
03/23/2010US7683243 Plants and seeds of hybrid corn variety CH525374
03/23/2010US7683242 Plants and seeds of hybrid corn variety CH338885
03/23/2010US7683241 Plants and seeds of hybrid corn variety CH244754
03/23/2010US7683240 Inbred maize line PH8ER
03/23/2010US7683239 Plants and seeds of corn variety CV390455
03/23/2010US7683238 Preparing transgenic plants for use as bioreactors in generation of therapeutic proteins; pharmacogenetics
03/23/2010US7683237 Maize seed with synergistically enhanced lysine content
03/23/2010US7683236 Enhanced production of cloned mammals by zona pellucida-free homologous mammalian embryo aggregation
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683159 Tenascin-W compositions and uses thereof
03/23/2010US7683036 especially nucleic acid and nucleic acid-like oligomers, which are targeted to or mimic nucleic acids comprising or encoding small non-coding RNAs, and which act to modulate the levels of small non-coding RNAs, or interfere with their function
03/23/2010US7683035 Method of stabilizing and/or isolating nucleic acids
03/23/2010US7683025 micelles; for loading or encapsulating polar drugs, DNA, mineralizable inorganic salts, and for small water-filled ion-conducting channels within their structure suitable for use in micro electromechanical devices,
03/23/2010US7682829 Inserting into tissue nucleic acid by inoculation with an Agrobacterium, culturing and regenerating; elevated temperatures; faster and more efficient
03/23/2010US7682828 Transgenic cells expressing pluripotency gene(s) for use in regenerative medicines; tissue engineering and repair
03/23/2010US7682825 inducing differentiation to dopaminergic neurons, or to skeletal muscle cells; for neurodegenerative and skeletal muscle degenerative diseases; bone marrow stromal cells
03/23/2010US7682818 Cylindrical syringe comprised of solid phase organic polymer for use in separation and isolation of nucleotide sequences
03/23/2010US7682790 Aqueous solution containing cationic stabilizer; plasmids; genomes; kits
03/23/2010US7682786 detection of a nucleic acid or a non-natural nucleic acid binding partner, a method for discriminating nucleic acid; used to enhance the sensitivity in diagnostic assays and to avoid stringency washes to dehybridize complexes containing targets which are not perfectly matching the probe
03/23/2010US7682626 Polyvinylethers for delivery of polynucleotides to mammalian cells
03/23/2010US7682607 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
03/23/2010CA2482865C Device for mixing and/or injecting cements
03/23/2010CA2425321C Plant cell death system
03/23/2010CA2389808C Antibodies to bis[sulfosuccinimidyl] suberate (bs3) or disuccinimidyl suberate (dss) as labels for proteins and nucleic acids
03/23/2010CA2332488C Cells and animals deficient in protein kinase c epsilon
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2283535C Glycine transporter
03/23/2010CA2236168C Disruption of expression of multiple alleles of mammalian genes
03/23/2010CA2225388C Low pathogenicity prrs live virus vaccines and methods of preparation thereof
03/23/2010CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2194797C Nucleic acid containing composition, preparation and uses of same
03/23/2010CA2193101C Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay
03/18/2010WO2010031083A2 Methods, systems and compositions related to reduction of conversions of microbially produced 3-hydroxypropionic acid (3-hp) to aldehyde metabolites
03/18/2010WO2010031074A2 Compositions and methods for regulating cell osmolarity
03/18/2010WO2010031007A2 Matrices and media for storage and stabilization of biomolecules
03/18/2010WO2010030986A2 Clean genome bactofection
03/18/2010WO2010030976A2 Methods and compositions for inhibiting atherosclerosis and vascular inflammation
03/18/2010WO2010030963A2 Modulation of bcl11a for treatment of hemoglobinopathies
03/18/2010WO2010030931A1 Oligonucleotides targeting human endogenous retrovirus 9 (erv-9) long terminal repeat (ltr) and methods of use
03/18/2010WO2010030840A2 Novel receptor and uses thereof
03/18/2010WO2010030776A1 Homologous recombination-based dna cloning methods and compositions
03/18/2010WO2010030653A2 Nurr1 interacting protein (nuip)
03/18/2010WO2010030600A2 Methods and compositions for personalization of dietary supplements based on genetic markers
03/18/2010WO2010030554A1 Genetically modified seed combined with spore forming bacterium and optional insect control agents
03/18/2010WO2010030337A1 Method and system for protection and cross protection of algae and cyanobacteria from virus and bacteriophage infections
03/18/2010WO2010030171A1 Method for diagnostic marker development
03/18/2010WO2010030140A2 A prokaryotic expansin protein for activating cellulose expansion and cellulose-degrading composition comprising the same
03/18/2010WO2010030049A1 Composition for detection of m. tuberculosis complex or mycobacteria genus and simultaneous detection method for m. tuberculosis complex and mycobacteria genus with multiplex real time pcr using the same
03/18/2010WO2010030035A1 Impedance spectroscopy measurement of dna
03/18/2010WO2010030003A1 System for regulating expression of multiple genes for use in reprogramming of cell
03/18/2010WO2010030002A1 Cell capable of expressing exogenous gitr ligand
03/18/2010WO2010029685A1 Method for designing mutant enzyme, method for preparing mutant enzyme, and mutant enzyme
03/18/2010WO2010029629A1 Dna-containing ink composition
03/18/2010WO2010029612A1 Glucose-induced inactivation/degradation resistance transporter gene and use of the same
03/18/2010WO2010029610A1 Hybrid alpha-glucoside transporter
03/18/2010WO2010029609A1 Glucose-induced inactivation/degradation resistant transporter gene and use thereof
03/18/2010WO2010029378A2 Anti-protozoa compounds
03/18/2010WO2010029357A2 Biomass
03/18/2010WO2010029311A2 Herbicide tolerant plants
03/18/2010WO2010029303A1 Gene silencing
03/18/2010WO2010029260A1 Synthetic gene construct encoding an hiv-1 gag and the use thereof for obtaining anti-hiv-1 vaccines
03/18/2010WO2010029259A1 Beta-glucosidase variants having improved activity, and uses thereof
03/18/2010WO2010029206A1 Procedure for producing transgenic plants providing high starch content and yield and high amylose/amylopectin balance
03/18/2010WO2010029178A1 Factor ix polypeptide mutant, its uses and a method for its production
03/18/2010WO2010029118A1 Method for identifying compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
03/18/2010WO2010028849A1 Attenuated liver-stage plasmodium and vaccine containing the same
03/18/2010WO2010028456A1 Modification of fructan biosynthesis, increasing plant biomass, and enhancing productivity of biochemical pathways in a plant
03/18/2010WO2010028443A1 Microrna target identification assay
03/18/2010WO2010011907A3 Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof
03/18/2010WO2010007495A3 Stress tolerant transgenic plants
03/18/2010WO2010006973A3 Compositions and methods for inhibiting expression of tgf-beta receptor genes
03/18/2010WO2010005551A3 Heterologous expression of termite cellulases in yeast
03/18/2010WO2010002548A3 Multi-gene expression vectors
03/18/2010WO2009158409A3 Pimap39 modulates inflammatory response
03/18/2010WO2009152500A3 Methods and compositions for mediating gene silencing
03/18/2010WO2009151546A3 Methods for treating spinal muscular atrophy